BioNexus Gene Lab (BGLC) Gross Profit (2018 - 2025)
BioNexus Gene Lab's Gross Profit history spans 8 years, with the latest figure at -$3983.0 for Q4 2025.
- Quarterly results put Gross Profit at -$3983.0 for Q4 2025, down 101.29% from a year ago — trailing twelve months through Dec 2025 was $1.1 million (down 15.84% YoY), and the annual figure for FY2025 was $1.1 million, down 15.84%.
- Gross Profit for Q4 2025 was -$3983.0 at BioNexus Gene Lab, down from $377685.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $709194.0 in Q3 2021 to a low of -$3983.0 in Q4 2025.
- The 5-year median for Gross Profit is $348912.5 (2023), against an average of $359989.9.
- The sharpest move saw Gross Profit soared 193.56% in 2021, then crashed 101.29% in 2025.
- Year by year, Gross Profit stood at $477167.0 in 2021, then fell by 28.91% to $339226.0 in 2022, then fell by 21.42% to $266555.0 in 2023, then rose by 16.01% to $309234.0 in 2024, then crashed by 101.29% to -$3983.0 in 2025.
- According to Business Quant data, Gross Profit over the past three periods came in at -$3983.0, $377685.0, and $368022.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.